RZLT's three largest insider shareholders as of September 29, 2026 are Young-Jin Kim (Director, 8.42Mn shares), Nevan C Elam (Ceo, 605.50K shares), Daron Evans (Cfo, 411.40K shares).
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Nevan C Elam | Ceo | 605,497 | 0 | 605,497 | 30.6% | 07 Jul, 2026 |
| 2 | Daron Evans | Cfo | 411,400 | 0 | 411,400 | 20.8% | 07 Jul, 2026 |
| 3 | Brian Kenneth Roberts | Chief Medical Officer | 316,403 | 0 | 316,403 | 16.0% | 07 Jul, 2026 |
| 4 | Young-Jin Kim | Director | 170,950 | 0 | 170,950 | 8.6% | 20 Nov, 2025 |
| 5 | Wladimir Hogenhuis | Director | 161,442 | 0 | 161,442 | 8.2% | 17 Dec, 2025 |
| 6 | Gil M Labrucherie | Director | 55,500 | 53,572 | 109,072 | 5.5% | 20 Nov, 2025 |
| 7 | Sunil Ratilal Karnawat | Chief Commercial Officer | 69,275 | 0 | 69,275 | 3.5% | 03 Sep, 2026 |
| 8 | Nerissa Kreher | Director | 58,576 | 0 | 58,576 | 3.0% | 21 Nov, 2025 |
| 9 | Philippe Fauchet | Director | 55,500 | 0 | 55,500 | 2.8% | 20 Nov, 2025 |
| 10 | Erik Harris | Director | 21,000 | 0 | 21,000 | 1.1% | 20 Nov, 2025 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 02 Sep, 2026 | Sunil Ratilal Karnawat | Chief Commercial Officer | Disposed F | 2,267 | $4.50 | $10.20K | 69,275 | Direct |
| 02 Jul, 2026 | Nevan C Elam | Ceo | Disposed F | 8,004 | $4.99 | $39.94K | 605,497 | Direct |
| 02 Jul, 2026 | Brian Kenneth Roberts | Chief Medical Officer | Disposed F | 3,062 | $4.99 | $15.28K | 293,851 | Direct |
| 02 Jul, 2026 | Daron Evans | Cfo | Disposed F | 3,062 | $4.99 | $15.28K | 411,400 | Direct |
| 30 Mar, 2026 | Daron Evans | Cfo | Acquired P | 10,000 | $2.85 | $28.50K | 414,462 | Direct |
| 02 Mar, 2026 | Daron Evans | Cfo | Disposed F | 11,438 | $2.99 | $34.20K | 404,462 | Direct |
| 02 Mar, 2026 | Nevan C Elam | Ceo | Disposed F | 27,618 | $2.99 | $82.58K | 613,501 | Direct |
| 02 Mar, 2026 | Brian Kenneth Roberts | Chief Medical Officer | Disposed F | 11,439 | $2.99 | $34.20K | 296,913 | Direct |
| 16 Dec, 2025 | Brian Kenneth Roberts | Chief Medical Officer | Acquired P | 28,000 | $1.70 | $47.60K | 308,352 | Direct |
| 16 Dec, 2025 | Wladimir Hogenhuis | Director | Acquired P | 5,650 | $1.69 | $9.55K | 119,675 | Direct |
| 15 Dec, 2025 | Nevan C Elam | Ceo | Acquired P | 32,000 | $1.59 | $50.88K | 641,119 | Direct |
| 15 Dec, 2025 | Daron Evans | Cfo | Acquired P | 40,000 | $1.77 | $70.64K | 415,900 | Direct |
| 15 Dec, 2025 | Sunil Ratilal Karnawat | Chief Commercial Officer | Acquired P | 12,000 | $1.62 | $19.44K | 71,442 | Direct |
| 15 Dec, 2025 | Daron Evans | Cfo | Acquired P | 2,500 | $1.79 | $4.46K | 7,000 | Indirect |
| 15 Dec, 2025 | Sunil Ratilal Karnawat | Chief Commercial Officer | Acquired P | 100 | $1.60 | $160 | 71,542 | Direct |
| 15 Dec, 2025 | Daron Evans | Cfo | Acquired P | 2,500 | $1.79 | $4.48K | 7,000 | Indirect |
| 19 Nov, 2025 | Daron Evans | Cfo | Acquired A | 107,000 | $0.00 | $0 | 375,900 | Direct |
| 19 Nov, 2025 | Nevan C Elam | Ceo | Acquired A | 317,000 | $0.00 | $0 | 609,119 | Direct |
| 19 Nov, 2025 | Nerissa Kreher | Director | Acquired A | 21,000 | $0.00 | $0 | 58,576 | Direct |
| 19 Nov, 2025 | Wladimir Hogenhuis | Director | Acquired A | 21,000 | $0.00 | $0 | 114,025 | Direct |